Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575334
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fudan UniversityRecruitingNot Applicable
NCT07575334Recruiting
Not Applicable
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fud...
NCT07575724
Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity SarcomaSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot Yet RecruitingPhase 2
NCT07575724Not Yet Recruiting
Phase 2
Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on...Second Affiliated Hospita...
NCT07575308
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMBAlnylam PharmaceuticalsNot Yet RecruitingPhase 2
NCT07575308Not Yet Recruiting
Phase 2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Pa...Alnylam Pharmaceuticals
NCT07576829
Wrist Heavy Slow Resistance and Shoulder Stabilization Exercises on Pain, Grip Strength and Functional Ability in Lateral EpicondylitisUniversity of FaisalabadRecruitingNot Applicable
NCT07576829Recruiting
Not Applicable
Wrist Heavy Slow Resistance and Shoulder Stabilization Exercises on Pain, Grip S...University of Faisalabad
NCT07574944
Effectiveness of Simulation-based Training Delivered to Special Newborn Care Providers on Resuscitation Management and Kangaroo Mother Care: Simulation-based Training for Asyphxia in Babies Trial (STAR-Baby Trial)Development and Research Service International NepalNot Yet RecruitingNot Applicable
NCT07574944Not Yet Recruiting
Not Applicable
Effectiveness of Simulation-based Training Delivered to Special Newborn Care Pro...Development and Research...
NCT07575360
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Cholecystitis PatientsUniversity of BolognaCompleted
NCT07575360Completed
—
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Chole...University of Bologna
NCT07576374
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West IndiesCentre Hospitalier Universitaire de la GuadeloupeNot Yet Recruiting
NCT07576374Not Yet Recruiting
—
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Ind...Centre Hospitalier Univer...
NCT07576049
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La SapienzaEnrolling By Invitation
NCT07576049Enrolling By Invitation
—
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La Sap...
NCT07576556
Mindfulness Plus Supervised Rehabilitation vs Supervised Rehabilitation Alone for Chronic Neck Pain in Office WorkersUniversity of MonastirNot Yet RecruitingNot Applicable
NCT07576556Not Yet Recruiting
Not Applicable
Mindfulness Plus Supervised Rehabilitation vs Supervised Rehabilitation Alone fo...University of Monastir
NCT07576283
Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Training in PostpartumRiphah International UniversityRecruitingNot Applicable
NCT07576283Recruiting
Not Applicable
Comparative Effects of Hypopressive and Transverses Abdominis Focused Core Train...Riphah International Univ...
NCT07576543
Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After SurgeryFujian Medical University Union HospitalNot Yet RecruitingPhase 4
NCT07576543Not Yet Recruiting
Phase 4
Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Co...Fujian Medical University...
NCT07575516
Effectiveness of Ashwagandha in Schizophrenia Patients on RisperidoneHasanuddin UniversityCompletedPhase 2
NCT07575516Completed
Phase 2
Effectiveness of Ashwagandha in Schizophrenia Patients on RisperidoneHasanuddin University
NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sahlgrenska University HospitalNot Yet RecruitingPhase 2
NCT07576257Not Yet Recruiting
Phase 2
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili...Sahlgrenska University Ho...
NCT07576972
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576972Not Yet Recruiting
Not Applicable
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Med...
NCT07576660
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled TrialSoutheast University, ChinaNot Yet RecruitingPhase 3
NCT07576660Not Yet Recruiting
Phase 3
Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrom...Southeast University, Chi...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07574645
Spinal Dural Arteriovenous Fistula International Data and Outcomes RegistryThomas Jefferson UniversityRecruiting
NCT07574645Recruiting
—
Spinal Dural Arteriovenous Fistula International Data and Outcomes RegistryThomas Jefferson Universi...
NCT07576179
Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises Comparative Effect in DPNRiphah International UniversityRecruitingNot Applicable
NCT07576179Recruiting
Not Applicable
Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises C...Riphah International Univ...
NCT07575347
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)Institutul Clinic FundeniNot Yet Recruiting
NCT07575347Not Yet Recruiting
—
Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)Institutul Clinic Fundeni
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 24 (20%)
Phase 41 (5%)
Phase 31 (5%)